A single determination of C-reactive protein does not suffice to declare a patient with a diagnosis of axial spondyloarthritis ‘CRP-negative’

BACKGROUND: To be eligible to receive treatment with an anti-tumour necrosis factor (TNF), non-radiographic axial spondyloarthritis (nr-axSpA) patients require either elevated levels of C-reactive protein (CRP) (CRP > upper limit of normal (ULN)) or magnetic resonance imaging assessment showing i...

Descripción completa

Detalles Bibliográficos
Autores principales: Landewé, Robert, Nurminen, Tommi, Davies, Owen, Baeten, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137888/
https://www.ncbi.nlm.nih.gov/pubmed/30217232
http://dx.doi.org/10.1186/s13075-018-1707-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137888/
https://www.ncbi.nlm.nih.gov/pubmed/30217232
http://dx.doi.org/10.1186/s13075-018-1707-8

Ejemplares similares